Literature DB >> 1953009

Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children.

A N Alam1, N M Abdal, M A Wahed, B Rao, C A Kawser, M Hoque, M M Rahaman.   

Abstract

The role of prostacyclin in the pathogenesis of haemolytic uraemic syndrome was evaluated in 11 children with acute shigellosis. Plasma concentrations of 6-keto prostaglandin, F1 alpha, a stable metabolite of prostacyclin, were measured by radioimmunoassay during acute illness, early convalescence, and after clinical recovery. Its concentration was low during acute illness in each patient, returning to normal concentrations or above at the time of the last sample. These results suggest that plasma prostacyclin may be involved in the development of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953009      PMCID: PMC1793527          DOI: 10.1136/adc.66.10.1231

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Lisch nodules in neurofibromatosis type 1.

Authors:  M L Lubs; M S Bauer; M E Formas; B Djokic
Journal:  N Engl J Med       Date:  1991-05-02       Impact factor: 91.245

3.  Prostacyclin infusion in haemolytic-uraemic syndrome of children.

Authors:  T J Beattie; A V Murphy; M L Willoughby; J J Belch
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-15

4.  Prostanoids in hemolytic uremic syndrome.

Authors:  M J Stuart; R E Spitzer; R W Walenga; S Boone
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

5.  Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood.

Authors:  K A Jørgensen; R S Pedersen
Journal:  Thromb Res       Date:  1981-02-01       Impact factor: 3.944

6.  Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.

Authors:  D A Chamone; W C Proesmans; L A Monnens; P Binda ki Muaka; J G Vermylen
Journal:  Int J Pediatr Nephrol       Date:  1982-03

7.  Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives.

Authors:  S Túri; T J Beattie; J J Belch; A V Murphy
Journal:  Clin Nephrol       Date:  1986-04       Impact factor: 0.975

8.  Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions.

Authors:  G Defreyn; W Proesmans; S J Machin; F Lemmens; J Vermylen
Journal:  Clin Nephrol       Date:  1982-07       Impact factor: 0.975

9.  Isolation and characterization of the human tyrosine aminotransferase gene.

Authors:  R Rettenmeier; E Natt; H Zentgraf; G Scherer
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

10.  Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.

Authors:  M Levin; K B Elkon; T J Nokes; A M Buckle; M J Dillon; R M Hardisty; T M Barratt
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

View more
  3 in total

1.  Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis.

Authors:  R S Heyderman; N J Klein
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

2.  Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis.

Authors:  C M Taylor; C J Lote
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

Review 3.  Prostacyclin in diarrhoea-associated haemolytic uraemic syndrome.

Authors:  C M Taylor; C J Lote
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.